Severe headache as a monosymptom of cerebral venous sinus thrombosis: a case report with effective utilization of the SNNOOP10 approach-Reference-Cited by-同舟云学术

Severe headache as a monosymptom of cerebral venous sinus thrombosis: a case report with effective utilization of the SNNOOP10 approach

Published:2022-12-30 Issue: Volume: Page:52-57
ISSN:2738-2737
Container-title:Armenian Journal of Health & Medical Sciences
language:
Short-container-title:AJHMS

Author:

Yeganyan Garik¹,Sargsyan Hasmik²,Manukyan Mariam²,Schytz Henrik³,Khachatryan Samson⁴

Affiliation:

1. Department of Neurology, Vanadzor Medical Center, Vanadzor, Armenia

2. Department of Neurology, Erebouni Medical Center, Yerevan, Armenia

3. Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark

4. Department of Neurology and Neurosurgery, Avdalbekyan National Institute of Health, Yerevan, Armenia, Somnus Neurology Clinic, Yerevan, Armenia

Abstract

Introduction: Headache is one of the most common complaints worldwide with a lifelong prevalence of 96% in the general population. The worldwide prevalence of secondary headaches is estimated to be 18%. Running an extensive work-up, including imaging and blood tests are not recommended in every headache patient, since the risk of false-positive results and incidental findings is high. The SNNOOP10 list was proposed to identify red flags for secondary headaches. “Pattern change or recent onset of new headache” is one of the red flags in SNNOOP10.

Publisher

National Institute of Health

Reference15 articles.

1. Rizzoli P, Mullally WJ. Headache. Am J Med. 2018;131(1):1724.

2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.

3. Do TP, Remmers A, Schytz HW, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92(3):134-144.

4. García-Azorín D, Abelaira-Freire J, González-García N, et al. Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection. Cephalalgia. 2022;42(14):15211531.

5. Clarke CE, Edwards J, Nicholl DJ, Sivaguru A. Imaging results in a consecutive series of 530 new patients in the Birmingham Headache Service. J Neurol. 2010;257(8):12741278.